These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
95-3359658
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
One Park Place, Suite 600, Dublin, CA
|
|
94568
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
Large accelerated filer
|
x
|
Accelerated filer
|
o
|
|
|
|
|
|
|
Non-accelerated filer
|
o
(do not check if a smaller reporting company)
|
Smaller reporting company
|
o
|
|
|
|
|
|
|
Emerging growth company
|
o
|
|
|
|
|
|
|
Form 10-Q
Cross Reference
|
Page
|
|
Part I, Item 1.
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Part I, Item 2.
|
||
|
Part I, Item 3.
|
||
|
Part I, Item 4.
|
||
|
Part II, Item 1.
|
||
|
Part II, Item 1A.
|
||
|
Part II, Item 2.
|
||
|
Part II, Item 3.
|
||
|
Part II, Item 4.
|
||
|
Part II, Item 5.
|
||
|
Part II, Item 6.
|
||
|
|
|
|
|
|
|
|
|
FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
Completed the migration of existing clients from the SOI platform onto our common TriNet platform so that all our clients can benefit from our investment in platform and product improvements,
|
|
•
|
Continued to strengthen our leadership team with the addition of executives in our sales, marketing and operations functions,
|
|
•
|
Benefited from increased sales force retention and product pricing strength,
|
|
•
|
Benefited from increased medical plan enrollment,
|
|
•
|
Benefited from changes in October 2017 with one of our health insurance carriers, where we converted an insurance carrier contract from a guaranteed-cost to risk-based insurance plan, and
|
|
•
|
Continued to invest in improving our internal control environment to support our ongoing compliance with the requirements of Sarbanes-Oxley Act of 2002 (SOX).
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
Served almost
16,000
clients and co-employed
Average WSEs
of approximately
315,000
, a
4%
decrease
in
Average WSEs
compared to the same period in
2017
and
|
|
•
|
Processed approximately
$10.3 billion
in payroll and payroll tax payments for our clients, an increase of
5%
over the same period in
2017
.
|
|
•
|
Total revenues
increased
7%
to
$861 million
and
Net Service Revenues
increased
11%
to
$220 million
,
|
|
•
|
Operating income
increased
43%
to
$71 million
,
|
|
•
|
Our
effective income tax rate
decreased to
20%
,
|
|
•
|
Net income
increased
88%
to
$54 million
, or
$0.75
per diluted share and
Adjusted Net Income
increased
84%
to
$58 million
, and
|
|
•
|
Adjusted EBITDA
increased
45%
to
$91 million
.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
Three Months Ended March 31,
|
|
Percent
|
||||||||
|
(in millions, except per share and operating metrics data)
|
2018
|
|
2017
|
|
Change
|
||||||
|
Income Statement Data:
|
|
|
|
|
|
|
|||||
|
Total revenues
|
$
|
861
|
|
|
$
|
808
|
|
|
7
|
|
%
|
|
Operating income
|
71
|
|
|
50
|
|
|
43
|
|
|
||
|
Net income
|
54
|
|
|
29
|
|
|
88
|
|
|
||
|
Diluted net income per share of common stock
|
0.75
|
|
|
0.41
|
|
|
83
|
|
|
||
|
Non-GAAP measures
(1)
:
|
|
|
|
|
|
|
|||||
|
Net Service Revenues
(1)
|
220
|
|
|
199
|
|
|
11
|
|
|
||
|
Net Insurance Service Revenues
(1)
|
91
|
|
|
79
|
|
|
16
|
|
|
||
|
Adjusted EBITDA
(1)
|
91
|
|
|
63
|
|
|
45
|
|
|
||
|
Adjusted Net Income
(1)
|
58
|
|
|
32
|
|
|
84
|
|
|
||
|
|
|
|
|
|
|
|
|||||
|
Operating Metrics:
|
|
|
|
|
|
|
|||||
|
Total WSEs payroll and payroll taxes processed (in millions)
|
$
|
10,319
|
|
|
$
|
9,816
|
|
|
5
|
|
%
|
|
Average WSEs
|
314,561
|
|
|
327,803
|
|
|
(4
|
)
|
|
||
|
Total WSEs at period end
|
316,715
|
|
|
330,731
|
|
|
(4
|
)
|
|
||
|
|
|
|
|
|
|
|
|||||
|
Cash Flow Data:
|
|
|
|
|
|
|
|||||
|
Net cash used in operating activities
(2)
|
$
|
(536
|
)
|
|
$
|
(161
|
)
|
|
231
|
|
%
|
|
Net cash provided by (used in) investing activities
|
2
|
|
|
(7
|
)
|
|
127
|
|
|
||
|
Net cash used in financing activities
|
(19
|
)
|
|
(37
|
)
|
|
(48
|
)
|
|
||
|
(1)
|
Refer to Non-GAAP Financial Measures section in the following pages for definitions and reconciliations from GAAP measures.
|
|
(2)
|
Prior year balance has been retrospectively adjusted for Accounting Standards Update (ASU) 2016-18. Refer to Note 1 in Item 1 of this Form 10-Q for details.
|
|
(in millions)
|
March 31,
2018 |
|
December 31,
2017 |
|
Percent
Change |
|
|||||
|
Balance Sheet Data:
|
|
|
|
|
|
|
|||||
|
Cash and cash equivalents
|
$
|
330
|
|
|
$
|
336
|
|
|
(2
|
)
|
%
|
|
Working capital
|
247
|
|
|
234
|
|
|
5
|
|
|
||
|
Total assets
|
2,047
|
|
|
2,593
|
|
|
(21
|
)
|
|
||
|
Notes payable
|
413
|
|
|
423
|
|
|
(2
|
)
|
|
||
|
Total liabilities
|
1,785
|
|
|
2,387
|
|
|
(25
|
)
|
|
||
|
Total stockholders’ equity
|
262
|
|
|
206
|
|
|
28
|
|
|
||
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
Non-GAAP Measure
|
Definition
|
How We Use The Measure
|
|
Net Service Revenues
|
•
Sum of professional service revenues and Net Insurance Service Revenues, or total revenues less insurance costs.
|
• Provides a comparable basis of revenues on a net basis. Professional service revenues are represented net of client payroll costs whereas insurance service revenues are presented gross of insurance costs for financial reporting purposes.
• Acts as the basis to allocate resources to different functions and evaluates the effectiveness of our business strategies by each business function.
• Provides a measure, among others, used in the determination of incentive compensation for management.
|
|
Net Insurance Service Revenues
|
• Insurance service revenues less insurance costs.
|
• Is a component of Net Service Revenues.
• Provides a comparable basis of revenues on a net basis. Professional service revenues are represented net of client payroll costs whereas insurance service revenues are presented gross of insurance costs for financial reporting purposes. Promotes an understanding of our insurance services business by evaluating insurance service revenues net of WSE related costs which are substantially pass-through for the benefit of WSEs. Under GAAP, insurance service revenues and costs are recorded gross as we have latitude in establishing the price, service and supplier specifications.
• We also sometimes refer to Net Insurance Service Margin, which is the ratio of Net Insurance Revenue to Insurance Service Revenues.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
Adjusted EBITDA
|
• Net income, excluding the effects of:
- income tax provision,
- interest expense,
- depreciation,
- amortization of intangible assets, and
- stock-based compensation expense
|
• Provides period-to-period comparisons on a consistent basis and an understanding as to how our management evaluates the effectiveness of our business strategies by excluding certain non-cash charges such as depreciation and stock-based compensation recognized based on the estimated fair values. We believe these charges are not directly resulting from our core operations or indicative of our ongoing operations.
• Enhances comparisons to prior periods and, accordingly, facilitates the development of future projections and earnings growth prospects.
• Provides a measure, among others, used in the determination of incentive compensation for management.
• We also sometimes refer to Adjusted EBITDA Margin, which is the ratio of Adjusted EBITDA to Net Service Revenues.
|
|
Adjusted Net Income
|
• Net income, excluding the effects of:
- effective income tax rate
(1)
,
- stock-based compensation,
- amortization of intangible assets,
- non-cash interest expense
(2)
, and
- the income tax effect (at our effective tax rate
(1)
) of these pre-tax adjustments.
|
• Provides information to our stockholders and board of directors to understand how our management evaluates our business, to monitor and evaluate our operating results, and analyze profitability of our ongoing operations and trends on a consistent basis by excluding certain non-cash charges as described above, debt payment premiums and our secondary offering costs as these are not directly resulting from our core operations or indicative of our ongoing operations.
|
|
(1)
|
We have adjusted the non-GAAP effective tax rate to
26%
for
2018
from
41%
for
2017
due primarily to a decrease in the statutory rate from 35% to 21%. These non-GAAP effective tax rates exclude the income tax impact from stock-based compensation, changes in uncertain tax positions, and nonrecurring benefits or expenses from federal legislative changes.
|
|
(2)
|
Non-cash interest expense represents amortization and write-off of our debt issuance costs.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
Three Months Ended
March 31, |
||||||
|
(in millions)
|
2018
|
|
2017
|
||||
|
Total revenues
|
$
|
861
|
|
|
$
|
808
|
|
|
Less: Insurance costs
|
641
|
|
|
609
|
|
||
|
Net Service Revenues
|
$
|
220
|
|
|
$
|
199
|
|
|
|
Three Months Ended
March 31, |
||||||
|
(in millions)
|
2018
|
|
2017
|
||||
|
Insurance service revenues
|
$
|
732
|
|
|
$
|
688
|
|
|
Less: Insurance costs
|
641
|
|
|
609
|
|
||
|
Net Insurance Service Revenues
|
$
|
91
|
|
|
$
|
79
|
|
|
Net Insurance Service Revenue Margin
(1)
|
12
|
%
|
|
11
|
%
|
||
|
(1)
|
Net Insurance Service Revenue Margin is calculated as the ratio of Net Insurance Service Revenues (a non-GAAP measure) to Insurance Service Revenues (a GAAP measure).
|
|
|
Three Months Ended
March 31, |
||||||
|
(in millions)
|
2018
|
|
2017
|
||||
|
Net income
|
$
|
54
|
|
|
$
|
29
|
|
|
Provision for income taxes
|
13
|
|
|
16
|
|
||
|
Stock-based compensation
|
9
|
|
|
6
|
|
||
|
Interest expense and bank fees
|
6
|
|
|
5
|
|
||
|
Depreciation
|
8
|
|
|
6
|
|
||
|
Amortization of intangible assets
|
1
|
|
|
1
|
|
||
|
Adjusted EBITDA
|
$
|
91
|
|
|
$
|
63
|
|
|
Adjusted EBITDA Margin
(1)
|
41
|
%
|
|
32
|
%
|
||
|
(1)
|
Adjusted EBITDA Margin is calculated as the ratio of Adjusted EBITDA (a non-GAAP measure) to Net Service Revenues (a non-GAAP measure).
|
|
|
Three Months Ended
March 31, |
||||||
|
(in millions)
|
2018
|
|
2017
|
||||
|
Net income
|
$
|
54
|
|
|
$
|
29
|
|
|
Effective income tax rate adjustment
|
(4
|
)
|
|
(2
|
)
|
||
|
Stock-based compensation
|
9
|
|
|
6
|
|
||
|
Amortization of intangible assets
|
1
|
|
|
1
|
|
||
|
Non-cash interest expense
|
1
|
|
|
1
|
|
||
|
Income tax impact of pre-tax adjustments
|
(3
|
)
|
|
(3
|
)
|
||
|
Adjusted Net Income
|
$
|
58
|
|
|
$
|
32
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
Insurance service revenues grew
7%
over the same quarter in
2017
to
$732 million
due primarily to increased participation in our health plans combined with an increase in health insurance service fees per plan participant, partially offset by a decline in Average WSEs.
|
|
•
|
Professional service revenues
increased
7%
over the same quarter in
2017
to
$129 million
due primarily to rate increases.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
•
|
Total compensation costs
increased
$7 million
, or
7%
, primarily due to a:
|
|
▪
|
$16 million increase associated with the following functions:
|
|
▪
|
client services and information technology to support the growth and migration of clients to our common TriNet platform,
|
|
▪
|
risk service to strengthen our insurance business, and
|
|
▪
|
other support functions as a result of increased operational and compliance requirements,
|
|
▪
|
partially offset by a decrease of $9 million in commission expense with the adoption of ASC Topic 606 in the first quarter of 2018. Refer to Note 1 in Item 1 of this Form 10-Q for additional details surrounding the impact of this adoption.
|
|
•
|
Consulting expenses
decreased
$3 million
primarily due to increased capitalization of costs related to our enhanced product offerings.
|
|
•
|
Other expenses
decreased
$6 million
primarily due to the timing of compliance costs.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
March 31, 2018
|
December 31, 2017
|
||||||||||||||||
|
(in millions)
|
Corporate
|
WSE
|
Total
|
Corporate
|
WSE
|
Total
|
||||||||||||
|
Current assets
|
|
|
|
|
|
|
||||||||||||
|
WSE-related assets
|
$
|
—
|
|
$
|
368
|
|
$
|
368
|
|
$
|
—
|
|
$
|
360
|
|
$
|
360
|
|
|
Cash and cash equivalents
|
330
|
|
—
|
|
330
|
|
336
|
|
—
|
|
336
|
|
||||||
|
Restricted cash, cash equivalents and investments
|
15
|
|
684
|
|
699
|
|
15
|
|
1,265
|
|
1,280
|
|
||||||
|
All other current assets
|
22
|
|
—
|
|
22
|
|
15
|
|
—
|
|
15
|
|
||||||
|
Current assets
|
$
|
367
|
|
$
|
1,052
|
|
$
|
1,419
|
|
$
|
366
|
|
$
|
1,625
|
|
$
|
1,991
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|||||||||
|
WSE-related liabilities
|
$
|
—
|
|
$
|
1,052
|
|
$
|
1,052
|
|
$
|
—
|
|
$
|
1,618
|
|
$
|
1,618
|
|
|
All other current liabilities
|
120
|
|
—
|
|
120
|
|
139
|
|
—
|
|
139
|
|
||||||
|
Current liabilities
|
$
|
120
|
|
$
|
1,052
|
|
$
|
1,172
|
|
$
|
139
|
|
$
|
1,618
|
|
$
|
1,757
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Working capital
|
$
|
247
|
|
$
|
—
|
|
$
|
247
|
|
$
|
227
|
|
$
|
7
|
|
$
|
234
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
Three Months Ended
March 31, |
|||||||||||||||||
|
(in millions)
|
2018
|
2017
|
||||||||||||||||
|
|
Corporate
|
WSE
|
Total
|
Corporate
|
WSE
|
Total
|
||||||||||||
|
Net cash provided by (used in):
|
|
|
|
|
|
|
||||||||||||
|
Operating activities
(1)
|
$
|
45
|
|
$
|
(581
|
)
|
$
|
(536
|
)
|
$
|
76
|
|
$
|
(237
|
)
|
$
|
(161
|
)
|
|
Investing activities
|
2
|
|
—
|
|
2
|
|
(7
|
)
|
—
|
|
(7
|
)
|
||||||
|
Financing activities
|
(19
|
)
|
—
|
|
(19
|
)
|
(37
|
)
|
—
|
|
(37
|
)
|
||||||
|
Net increase (decrease) in cash and cash equivalents, unrestricted and restricted
|
$
|
28
|
|
$
|
(581
|
)
|
$
|
(553
|
)
|
$
|
32
|
|
$
|
(237
|
)
|
$
|
(205
|
)
|
|
Cash and cash equivalents, unrestricted and restricted:
|
|
|
|
|
|
|
||||||||||||
|
Beginning of period
|
476
|
|
1,262
|
|
1,738
|
|
278
|
|
955
|
|
1,233
|
|
||||||
|
End of period
|
$
|
504
|
|
$
|
681
|
|
$
|
1,185
|
|
$
|
310
|
|
$
|
718
|
|
$
|
1,028
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Net increase (decrease) in cash and cash equivalents:
|
|
|
|
|
|
|
||||||||||||
|
Unrestricted
|
$
|
(6
|
)
|
$
|
—
|
|
$
|
(6
|
)
|
$
|
32
|
|
$
|
—
|
|
$
|
32
|
|
|
Restricted
|
$
|
34
|
|
$
|
(581
|
)
|
$
|
(547
|
)
|
$
|
—
|
|
$
|
(237
|
)
|
$
|
(237
|
)
|
|
(1)
|
Prior year balances were retrospectively adjusted for Accounting Standards Update (ASU) 2016-18. Refer to Note 1 in Item 1 of this Form 10-Q for details.
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
Three Months Ended
March 31, |
|||||||||||||||||
|
(in millions)
|
2018
|
2017
|
||||||||||||||||
|
|
Corporate
|
WSE
|
Total
|
Corporate
|
WSE
|
Total
|
||||||||||||
|
Net income
|
$
|
54
|
|
$
|
—
|
|
$
|
54
|
|
$
|
29
|
|
$
|
—
|
|
$
|
29
|
|
|
Depreciation and amortization
|
10
|
|
—
|
|
10
|
|
8
|
|
—
|
|
8
|
|
||||||
|
Stock-based compensation expense
|
9
|
|
—
|
|
9
|
|
6
|
|
—
|
|
6
|
|
||||||
|
Payment of interest
|
(4
|
)
|
—
|
|
(4
|
)
|
(4
|
)
|
—
|
|
(4
|
)
|
||||||
|
Income tax (payments) refunds, net
|
—
|
|
—
|
|
—
|
|
1
|
|
—
|
|
1
|
|
||||||
|
Changes in other operating assets
|
(2
|
)
|
(15
|
)
|
(17
|
)
|
14
|
|
5
|
|
19
|
|
||||||
|
Changes in other operating liabilities
|
(22
|
)
|
(566
|
)
|
(588
|
)
|
22
|
|
(242
|
)
|
(220
|
)
|
||||||
|
Net cash provided by (used in) operating activities
(1)
|
$
|
45
|
|
$
|
(581
|
)
|
$
|
(536
|
)
|
$
|
76
|
|
$
|
(237
|
)
|
$
|
(161
|
)
|
|
(1)
|
Prior year balances were retrospectively adjusted for Accounting Standards Update (ASU) 2016-18. Refer to Note 1 in Item 1 of this Form 10-Q for details.
|
|
|
Three Months Ended
March 31, |
|||||
|
(in millions)
|
2018
|
2017
|
||||
|
Capital expenditures:
|
|
|
||||
|
Software and hardware
|
$
|
6
|
|
$
|
6
|
|
|
Office furniture, equipment and leasehold improvements
|
6
|
|
5
|
|
||
|
Cash used in capital expenditures
|
$
|
12
|
|
$
|
11
|
|
|
|
|
|
||||
|
Investments:
|
|
|
||||
|
Proceeds from maturity of restricted investments
|
14
|
|
4
|
|
||
|
Cash provided by investments
|
$
|
14
|
|
$
|
4
|
|
|
|
|
|
|
MANAGEMENT'S DISCUSSION AND ANALYSIS
|
|
|
|
|
|
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
AND CONTROLS AND PROCEDURES
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
(in millions, except share and per share data)
|
March 31,
2018 |
|
December 31,
2017 |
||||||||||
|
Assets
|
|
|
|
|
|
||||||||
|
Current assets:
|
|
|
|
|
|
||||||||
|
Cash and cash equivalents
|
|
$
|
330
|
|
|
|
$
|
336
|
|
||||
|
Restricted cash, cash equivalents and investments
|
|
699
|
|
|
|
1,280
|
|
||||||
|
Worksite employee related assets:
|
|
|
|
|
|
||||||||
|
Unbilled revenue (net of advance collections of $12 and $12 at March 31, 2018 and December 31, 2017, respectively)
|
$
|
286
|
|
|
|
$
|
297
|
|
|
||||
|
Accounts receivable
|
8
|
|
|
|
20
|
|
|
||||||
|
Prepaid insurance premiums and other insurance related receivables
|
33
|
|
|
|
26
|
|
|
||||||
|
Other payroll assets
|
41
|
|
|
|
17
|
|
|
||||||
|
Worksite employee related assets
|
|
|
368
|
|
|
|
|
360
|
|
||||
|
Prepaid expenses and other current assets
|
|
22
|
|
|
|
15
|
|
||||||
|
Total current assets
|
|
1,419
|
|
|
|
1,991
|
|
||||||
|
Restricted cash, cash equivalents and investments, noncurrent
|
|
182
|
|
|
|
162
|
|
||||||
|
Workers' compensation collateral receivable
|
|
40
|
|
|
|
39
|
|
||||||
|
Property and equipment, net
|
|
74
|
|
|
|
70
|
|
||||||
|
Goodwill and other intangible assets, net
|
|
314
|
|
|
|
315
|
|
||||||
|
Other assets
|
|
18
|
|
|
|
16
|
|
||||||
|
Total assets
|
|
$
|
2,047
|
|
|
|
$
|
2,593
|
|
||||
|
Liabilities and stockholders’ equity
|
|
|
|
|
|
||||||||
|
Current liabilities:
|
|
|
|
|
|
||||||||
|
Accounts payable and other current liabilities
|
|
$
|
46
|
|
|
|
$
|
59
|
|
||||
|
Accrued corporate wages
|
|
31
|
|
|
|
40
|
|
||||||
|
Notes payable
|
|
43
|
|
|
|
40
|
|
||||||
|
Worksite employee related liabilities:
|
|
|
|
|
|
||||||||
|
Accrued wages
|
$
|
284
|
|
|
|
$
|
289
|
|
|
||||
|
Client deposits
|
26
|
|
|
|
52
|
|
|
||||||
|
Payroll tax liabilities and other payroll withholdings
|
500
|
|
|
|
1,034
|
|
|
||||||
|
Health benefits loss reserves (net of prepayments of $30 and $19 at March 31, 2018 and December 31, 2017, respectively)
|
150
|
|
|
|
151
|
|
|
||||||
|
Workers' compensation loss reserves (net of collateral paid of $5 and $6 at March 31, 2018 and December 31, 2017, respectively)
|
67
|
|
|
|
67
|
|
|
||||||
|
Insurance premiums and other payables
|
25
|
|
|
|
25
|
|
|
||||||
|
Worksite employee related liabilities
|
|
|
1,052
|
|
|
|
|
1,618
|
|
||||
|
Total current liabilities
|
|
1,172
|
|
|
|
1,757
|
|
||||||
|
Notes payable, noncurrent
|
|
370
|
|
|
|
383
|
|
||||||
|
Workers' compensation loss reserves
(net of collateral paid of $16 and $17 at March 31, 2018 and December 31, 2017, respectively) |
|
162
|
|
|
|
165
|
|
||||||
|
Deferred income taxes
|
|
71
|
|
|
|
68
|
|
||||||
|
Other liabilities
|
|
10
|
|
|
|
14
|
|
||||||
|
Total liabilities
|
|
1,785
|
|
|
|
2,387
|
|
||||||
|
Commitments and contingencies (see Note 8)
|
|
|
|
|
|
|
|
||||||
|
Stockholders’ equity:
|
|
|
|
|
|
||||||||
|
Preferred stock
($0.000025 par value per share; 20,000,000 shares authorized; no shares issued and outstanding at March 31, 2018 and December 31, 2017) |
|
—
|
|
|
|
—
|
|
||||||
|
Common stock and additional paid-in capital
($0.000025 par value per share; 750,000,000 shares authorized; 70,363,251 and 69,818,392 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively) |
|
595
|
|
|
|
583
|
|
||||||
|
Accumulated deficit
|
|
(332
|
)
|
|
|
(377
|
)
|
||||||
|
Accumulated other comprehensive loss
|
|
(1
|
)
|
|
|
—
|
|
||||||
|
Total stockholders’ equity
|
|
262
|
|
|
|
206
|
|
||||||
|
Total liabilities and stockholders’ equity
|
|
$
|
2,047
|
|
|
|
$
|
2,593
|
|
||||
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Three Months Ended
March 31, |
|||||
|
(in millions, except share and per share data)
|
2018
|
2017
|
||||
|
Professional service revenues
|
$
|
129
|
|
$
|
120
|
|
|
Insurance service revenues
|
732
|
|
688
|
|
||
|
Total revenues
|
861
|
|
808
|
|
||
|
Insurance costs
|
641
|
|
609
|
|
||
|
Cost of providing services (exclusive of depreciation and amortization of intangible assets)
|
57
|
|
57
|
|
||
|
Sales and marketing
|
39
|
|
49
|
|
||
|
General and administrative
|
31
|
|
25
|
|
||
|
Systems development and programming
|
13
|
|
11
|
|
||
|
Depreciation
|
8
|
|
6
|
|
||
|
Amortization of intangible assets
|
1
|
|
1
|
|
||
|
Total costs and operating expenses
|
790
|
|
758
|
|
||
|
Operating income
|
71
|
|
50
|
|
||
|
Other income (expense):
|
|
|
||||
|
Interest expense, bank fees and other, net
|
(4
|
)
|
(5
|
)
|
||
|
Income before provision for income taxes
|
67
|
|
45
|
|
||
|
Income tax expense
|
13
|
|
16
|
|
||
|
Net income
|
$
|
54
|
|
$
|
29
|
|
|
Comprehensive income
|
$
|
54
|
|
$
|
29
|
|
|
|
|
|
||||
|
Net income per share:
|
|
|
||||
|
Basic
|
$
|
0.77
|
|
$
|
0.42
|
|
|
Diluted
|
$
|
0.75
|
|
$
|
0.41
|
|
|
Weighted average shares:
|
|
|
||||
|
Basic
|
70,047,752
|
|
68,509,328
|
|
||
|
Diluted
|
72,274,821
|
|
70,913,970
|
|
||
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Three Months Ended
March 31, |
|||||
|
(in millions)
|
2018
|
2017
|
||||
|
Operating activities
|
|
|
||||
|
Net income
|
$
|
54
|
|
$
|
29
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||||
|
Depreciation and amortization
|
10
|
|
8
|
|
||
|
Stock-based compensation
|
9
|
|
6
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
||||
|
Prepaid income taxes
|
13
|
|
15
|
|
||
|
Prepaid expenses and other current assets
|
(9
|
)
|
2
|
|
||
|
Workers' compensation collateral receivable
|
(1
|
)
|
(3
|
)
|
||
|
Other assets
|
(2
|
)
|
—
|
|
||
|
Accounts payable and other current liabilities
|
(15
|
)
|
2
|
|
||
|
Accrued corporate wages
|
(9
|
)
|
10
|
|
||
|
Workers' compensation loss reserves and other non-current liabilities
|
(6
|
)
|
8
|
|
||
|
Worksite employee related assets
|
(14
|
)
|
4
|
|
||
|
Worksite employee related liabilities
|
(566
|
)
|
(242
|
)
|
||
|
Net cash used in operating activities
|
(536
|
)
|
(161
|
)
|
||
|
Investing activities
|
|
|
||||
|
Proceeds from maturity of marketable securities
|
14
|
|
4
|
|
||
|
Acquisitions of property and equipment
|
(12
|
)
|
(11
|
)
|
||
|
Net cash provided by (used in) investing activities
|
2
|
|
(7
|
)
|
||
|
Financing activities
|
|
|
||||
|
Repurchase of common stock
|
(8
|
)
|
(28
|
)
|
||
|
Proceeds from issuance of common stock on exercised options
|
3
|
|
2
|
|
||
|
Awards effectively repurchased for required employee withholding taxes
|
(4
|
)
|
(2
|
)
|
||
|
Repayment of notes payable
|
(10
|
)
|
(9
|
)
|
||
|
Net cash used in financing activities
|
(19
|
)
|
(37
|
)
|
||
|
Net increase (decrease) in cash and cash equivalents, unrestricted and restricted
|
(553
|
)
|
(205
|
)
|
||
|
Cash and cash equivalents, unrestricted and restricted:
|
|
|
||||
|
Beginning of period
|
1,738
|
|
1,233
|
|
||
|
End of period
|
$
|
1,185
|
|
$
|
1,028
|
|
|
|
|
|
||||
|
Supplemental disclosures of cash flow information
|
|
|
||||
|
Interest paid
|
$
|
4
|
|
$
|
4
|
|
|
Income taxes paid (refunded), net
|
—
|
|
(1
|
)
|
||
|
Supplemental schedule of noncash investing and financing activities
|
|
|
||||
|
Payable for purchase of property and equipment
|
$
|
2
|
|
$
|
2
|
|
|
Supplemental schedule of cash and cash equivalents
|
|
|
||||
|
Net increase (decrease) in unrestricted cash and cash equivalents
|
$
|
(6
|
)
|
$
|
32
|
|
|
Net increase (decrease) in restricted cash and cash equivalents
|
(547
|
)
|
(237
|
)
|
||
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
•
|
compensation through wages and salaries,
|
|
•
|
employer payroll-related tax payments,
|
|
•
|
employee payroll-related tax withholdings and payments,
|
|
•
|
employee benefit programs including health and life insurance, and others, and
|
|
•
|
workers' compensation coverage.
|
|
•
|
liability for unpaid losses and loss adjustment expenses (loss reserves) related to workers' compensation and workers' compensation collateral receivable,
|
|
•
|
health insurance loss reserves,
|
|
•
|
liability for insurance premiums payable,
|
|
•
|
impairments of goodwill and other intangible assets,
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
•
|
income tax assets and liabilities, and
|
|
•
|
liability for legal contingencies.
|
|
•
|
Our annual service contracts with our clients that are cancellable with 30 days' notice are initially considered 30-day contracts under the new standard;
|
|
•
|
Professional service revenues are recognized on an output basis which results in recognition at the time payroll is processed;
|
|
•
|
Our non-refundable set up fees are no longer deferred but accounted for as part of our transaction price and are allocated among professional service revenues and insurance services revenues; and
|
|
•
|
The majority of sales commissions related to onboarding new clients that were previously expensed are capitalized as contract assets and amortized over the estimated customer life.
|
|
•
|
Payroll and payroll tax processing,
|
|
•
|
Health benefits services, and
|
|
•
|
Workers’ compensation services.
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
•
|
corporate cash and cash equivalents in trust accounts functioning as security deposits for our insurance carriers,
|
|
•
|
payroll funds collected represents cash collected in advance from clients which we designate as restricted for the purpose of funding WSE payroll and payroll taxes and other payroll related liabilities, and
|
|
•
|
amounts held in trust for current and future premium and claim obligations with our insurance carriers, which amounts are held in trust according to the terms of the relevant insurance policies and by the local insurance regulations of the jurisdictions in which the policies are in force.
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
(in millions)
|
As of and for the
Three Months Ended
March 31, 2018
|
Balance Using Previous Standard
|
Increase (Decrease)
|
||||||
|
Income statement
|
|
|
|
||||||
|
Revenue
|
|
|
|
||||||
|
Professional service revenues
|
$
|
129
|
|
$
|
126
|
|
$
|
3
|
|
|
Total revenues
|
861
|
|
858
|
|
3
|
|
|||
|
Expense
|
|
|
|
||||||
|
Sales and marketing expense
|
|
|
|
|
|||||
|
Commissions expense
|
4
|
|
13
|
|
(9
|
)
|
|||
|
Total expense
|
790
|
|
799
|
|
(9
|
)
|
|||
|
Income before provision for income taxes
|
67
|
|
56
|
|
11
|
|
|||
|
Income tax expense
|
13
|
|
11
|
|
2
|
|
|||
|
Net income
|
54
|
|
45
|
|
9
|
|
|||
|
Basic earnings per share
|
0.77
|
|
0.64
|
|
0.13
|
|
|||
|
Diluted earnings per share
|
0.75
|
|
0.62
|
|
0.13
|
|
|||
|
|
|
|
|
|
|||||
|
Balance sheet
|
|
|
|
||||||
|
Assets
|
|
|
|
|
|||||
|
Unbilled revenue (net of advance collections)
|
$
|
286
|
|
$
|
291
|
|
$
|
(5
|
)
|
|
Prepaid expenses and other current assets
|
22
|
|
14
|
|
8
|
|
|||
|
Other assets
|
18
|
|
14
|
|
4
|
|
|||
|
Liabilities
|
|
|
|
|
|||||
|
Accounts payable and other current liabilities
|
46
|
|
47
|
|
(1
|
)
|
|||
|
Other liabilities
|
10
|
|
12
|
|
(2
|
)
|
|||
|
Equity
|
|
|
|
|
|||||
|
Retained earnings
|
(332
|
)
|
(342
|
)
|
10
|
|
|||
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
March 31, 2018
|
December 31, 2017
|
||||||||||||||||||||||
|
(in millions)
|
Cash and cash equivalents
|
Available for sale marketable securities
|
Certificate
of
deposits
|
Total
|
Cash and cash equivalents
|
Available for sale marketable securities
|
Certificate
of
deposits
|
Total
|
||||||||||||||||
|
Cash and cash equivalents
|
$
|
330
|
|
$
|
—
|
|
$
|
—
|
|
$
|
330
|
|
$
|
336
|
|
$
|
—
|
|
$
|
—
|
|
$
|
336
|
|
|
Restricted cash, cash equivalents and investments
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Insurance carriers security deposits
|
15
|
|
—
|
|
—
|
|
15
|
|
15
|
|
—
|
|
—
|
|
15
|
|
||||||||
|
Payroll funds collected
|
523
|
|
—
|
|
—
|
|
523
|
|
1,095
|
|
—
|
|
—
|
|
1,095
|
|
||||||||
|
Collateral for health benefits claims
|
71
|
|
—
|
|
—
|
|
71
|
|
69
|
|
—
|
|
—
|
|
69
|
|
||||||||
|
Collateral for workers' compensation claims
|
87
|
|
1
|
|
—
|
|
88
|
|
98
|
|
1
|
|
—
|
|
99
|
|
||||||||
|
Collateral to secure standby letter of credit
|
—
|
|
—
|
|
2
|
|
2
|
|
—
|
|
—
|
|
2
|
|
2
|
|
||||||||
|
Total restricted cash, cash equivalents and investments
|
696
|
|
1
|
|
2
|
|
699
|
|
1,277
|
|
1
|
|
2
|
|
1,280
|
|
||||||||
|
Restricted cash, cash equivalents and investments, noncurrent
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Collateral for workers' compensation claims
|
159
|
|
23
|
|
—
|
|
182
|
|
125
|
|
37
|
|
—
|
|
162
|
|
||||||||
|
Total
|
$
|
1,185
|
|
$
|
24
|
|
$
|
2
|
|
$
|
1,211
|
|
$
|
1,738
|
|
$
|
38
|
|
$
|
2
|
|
$
|
1,778
|
|
|
(in millions)
|
Maturity
(in years) |
Amortized Cost
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
||||||||
|
March 31, 2018
|
|
|
|
|
|
||||||||
|
U.S. treasuries
|
1-5 years
|
$
|
23
|
|
$
|
—
|
|
$
|
—
|
|
$
|
23
|
|
|
Exchange traded fund
|
N/A
|
1
|
|
—
|
|
—
|
|
1
|
|
||||
|
Total
|
|
$
|
24
|
|
$
|
—
|
|
$
|
—
|
|
$
|
24
|
|
|
|
|
|
|
|
|
||||||||
|
December 31, 2017
|
|
|
|
|
|
||||||||
|
U.S. treasuries
|
1-5 years
|
$
|
37
|
|
$
|
—
|
|
$
|
—
|
|
$
|
37
|
|
|
Exchange traded fund
|
N/A
|
1
|
|
—
|
|
—
|
|
1
|
|
||||
|
Total
|
|
$
|
38
|
|
$
|
—
|
|
$
|
—
|
|
$
|
38
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Three Months Ended
March 31, |
|||||
|
(in millions)
|
2018
|
2017
|
||||
|
Total loss reserves, beginning of period
|
$
|
255
|
|
$
|
255
|
|
|
Incurred
|
|
|
||||
|
Current year
|
20
|
|
27
|
|
||
|
Prior years
|
(7
|
)
|
1
|
|
||
|
Total incurred
|
13
|
|
28
|
|
||
|
Paid
|
|
|
||||
|
Current year
|
—
|
|
—
|
|
||
|
Prior years
|
(18
|
)
|
(22
|
)
|
||
|
Total paid
|
(18
|
)
|
(22
|
)
|
||
|
Total loss reserves, end of period
|
$
|
250
|
|
$
|
261
|
|
|
(in millions)
|
March 31,
2018 |
December 31,
2017 |
||||
|
Total loss reserves, end of period
|
$
|
250
|
|
$
|
255
|
|
|
Collateral paid to carriers and offset against loss reserves
|
(21
|
)
|
(23
|
)
|
||
|
Total loss reserves, net of carrier collateral offset
|
$
|
229
|
|
$
|
232
|
|
|
|
|
|
||||
|
Payable in less than 1 year
(net of collateral paid to carriers of $5 and $6 at March 31, 2018 and December 31, 2017, respectively) |
$
|
67
|
|
$
|
67
|
|
|
Payable in more than 1 year
(net of collateral paid to carriers of $16 and $17 at March 31, 2018 and December 31, 2017, respectively) |
162
|
|
165
|
|
||
|
Total loss reserves, net of carrier collateral offset
|
$
|
229
|
|
$
|
232
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
(in millions)
|
Level 1
|
Level 2
|
Total
|
||||||
|
March 31, 2018
|
|
|
|
||||||
|
Restricted cash equivalents:
|
|
|
|
||||||
|
Money market mutual funds
|
$
|
224
|
|
$
|
—
|
|
$
|
224
|
|
|
Commercial paper
|
20
|
|
—
|
|
20
|
|
|||
|
Total restricted cash equivalents
|
244
|
|
—
|
|
244
|
|
|||
|
Restricted investments:
|
|
|
|
||||||
|
U.S. Treasuries
|
23
|
|
—
|
|
23
|
|
|||
|
Exchange traded fund
|
1
|
|
—
|
|
1
|
|
|||
|
Certificate of deposit
|
—
|
|
2
|
|
2
|
|
|||
|
Total restricted investments
|
24
|
|
2
|
|
26
|
|
|||
|
Total restricted cash equivalents and investments
|
$
|
268
|
|
$
|
2
|
|
$
|
270
|
|
|
|
|
|
|
||||||
|
December 31, 2017
|
|
|
|
||||||
|
Restricted cash equivalents:
|
|
|
|
||||||
|
Money market mutual funds
|
$
|
199
|
|
$
|
—
|
|
$
|
199
|
|
|
Commercial paper
|
21
|
|
—
|
|
21
|
|
|||
|
Total restricted cash equivalents
|
220
|
|
—
|
|
220
|
|
|||
|
Restricted investments:
|
|
|
|
||||||
|
U.S. Treasuries
|
37
|
|
—
|
|
37
|
|
|||
|
Exchange traded fund
|
1
|
|
—
|
|
1
|
|
|||
|
Certificate of deposit
|
—
|
|
2
|
|
2
|
|
|||
|
Total restricted investments
|
38
|
|
2
|
|
40
|
|
|||
|
Total restricted cash equivalents and investments
|
$
|
258
|
|
$
|
2
|
|
$
|
260
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Number
of Shares |
|
|
Balance at December 31, 2017
|
1,296,863
|
|
|
Exercised
|
(206,430
|
)
|
|
Forfeited
|
(4,167
|
)
|
|
Balance at March 31, 2018
|
1,086,266
|
|
|
Exercisable at March 31, 2018
|
1,011,038
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
RSUs
|
PSUs
|
||||||||
|
|
Number of Units
|
Weighted-Average
Grant Date
Fair Value
|
Number of Units
|
Weighted-Average
Grant Date
Fair Value
|
||||||
|
Nonvested at December 31, 2017
|
2,249,661
|
|
$
|
24.83
|
|
453,674
|
|
$
|
30.72
|
|
|
Granted
|
548,054
|
|
46.97
|
|
23,842
|
|
47.61
|
|
||
|
Vested
|
(286,121
|
)
|
23.96
|
|
(82,066
|
)
|
33.51
|
|
||
|
Forfeited
|
(88,396
|
)
|
25.51
|
|
—
|
|
—
|
|
||
|
Nonvested at March 31, 2018
|
2,423,198
|
|
$
|
29.91
|
|
395,450
|
|
$
|
30.89
|
|
|
|
RSAs
|
PRSAs
|
||||||||
|
|
Number of Units
|
Weighted-Average
Grant Date
Fair Value
|
Number of Units
|
Weighted-Average
Grant Date
Fair Value
|
||||||
|
Nonvested at December 31, 2017
|
—
|
|
$
|
—
|
|
—
|
|
$
|
—
|
|
|
Granted
|
72,991
|
|
47.61
|
|
169,088
|
|
47.61
|
|
||
|
Nonvested at March 31, 2018
|
72,991
|
|
$
|
47.61
|
|
169,088
|
|
$
|
47.61
|
|
|
|
Three Months Ended
March 31, |
|||||
|
(in millions)
|
2018
|
2017
|
||||
|
Cost of providing services
|
$
|
2
|
|
$
|
2
|
|
|
Sales and marketing
|
2
|
|
1
|
|
||
|
General and administrative
|
4
|
|
2
|
|
||
|
Systems development and programming costs
|
1
|
|
1
|
|
||
|
Total stock-based compensation expense
|
$
|
9
|
|
$
|
6
|
|
|
Income tax benefit related to stock-based compensation expense
|
$
|
2
|
|
$
|
2
|
|
|
Tax benefit realized from stock options exercised and similar awards
|
$
|
6
|
|
$
|
6
|
|
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
Three Months Ended
March 31, |
|||||
|
(in millions, except per share data)
|
2018
|
2017
|
||||
|
Net income
|
$
|
54
|
|
$
|
29
|
|
|
Weighted average shares of common stock outstanding
|
70
|
|
69
|
|
||
|
Basic EPS
|
$
|
0.77
|
|
$
|
0.42
|
|
|
|
|
|
||||
|
Net income
|
$
|
54
|
|
$
|
29
|
|
|
Weighted average shares of common stock
|
70
|
|
69
|
|
||
|
Dilutive effect of stock options and restricted stock units
|
2
|
|
2
|
|
||
|
Weighted average shares of common stock outstanding
|
72
|
|
71
|
|
||
|
Diluted EPS
|
$
|
0.75
|
|
$
|
0.41
|
|
|
|
|
|
||||
|
Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect
|
1
|
|
1
|
|
||
|
|
|
|
|
FINANCIAL STATEMENTS
|
|
|
|
|
|
|
OTHER INFORMATION
|
|
|
Period
|
Total Number of
Shares
Purchased
(1)
|
|
Weighted Average Price
Paid Per Share |
|
Total Number of
Shares Purchased as Part of Publicly Announced Plans (2) |
|
Approximate Dollar Value ($ millions)
of Shares that May Yet be Purchased Under the Plans (2) |
||||||
|
January 1 - January 31, 2018
|
2,325
|
|
|
$
|
43.13
|
|
|
—
|
|
|
$
|
136
|
|
|
February 1 - February 28, 2018
|
73,761
|
|
|
$
|
41.36
|
|
|
—
|
|
|
$
|
136
|
|
|
March 1 - March 31, 2018
|
195,751
|
|
|
$
|
47.31
|
|
|
160,033
|
|
|
$
|
129
|
|
|
Total
|
271,837
|
|
|
|
|
160,033
|
|
|
|
||||
|
(1)
|
Includes shares surrendered by employees to us to satisfy tax withholding obligations that arose upon vesting of restricted stock units granted pursuant to approved plans.
|
|
(2)
|
We repurchased a total of approximately
$8 million
of our outstanding common stock during the three months ended
March 31, 2018
.
|
|
|
|
|
|
EXHIBITS
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
||||||
|
Exhibit No.
|
|
Exhibit
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
|
10.1*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
10.2*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
10.3*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
10.4*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
10.5*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
32.1*
|
|
|
|
|
|
|
|
|
|
|
X
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
|
Document has been furnished, is deemed not filed and is not to be incorporated by reference into any of TriNet Group, Inc.’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing.
|
|
|
|
|
|
|
SIGNATURES
|
|
|
|
TRINET GROUP, INC.
|
||
|
|
|
||
|
Date: April 30, 2018
|
|
By:
|
/s/ Burton M. Goldfield
|
|
|
|
|
Burton M. Goldfield
|
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
|
Date: April 30, 2018
|
|
By:
|
/s/ Richard Beckert
|
|
|
|
|
Richard Beckert
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|
|
|
Date: April 30, 2018
|
|
By:
|
/s/ Michael P. Murphy
|
|
|
|
|
Michael P. Murphy
|
|
|
|
|
Chief Accounting Officer
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|